In the US, the drug sofisbuvir, brand name sovaldir, and used to treat liver disease hepatitis C, was launched with a price tag of $1000 a pill; and in the UK, the manufacturer Gilead recommended a twelve week course that costs £35,000.
There are roughly 160,000 people in the UK that require treatment and unprecedently the NHS chose to phase the drug in. This obviously has to do with the cost of the drug.
Q. What is the estimated revenue and profit margin for this drug?
Q. Are drug prices kept artificially high by firms that develop drugs for-profit?
Q.Are there measures by which we can measure excessive profiteering?
Q. Is there a cure for high prices in the pharmaceutical industry?
note: Despite criticism that there are too many questions in this post, I want to emphasise that it is actually one question which has been split up into several for emphasis. I’m not expecting anyone to answer all of them, it’s possible to choose one of them.**